GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Float Percentage Of Total Shares Outstanding

Inovio Pharmaceuticals (FRA:GBM) Float Percentage Of Total Shares Outstanding : 99.32% (As of Jun. 03, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Inovio Pharmaceuticals's float shares is 25.73 Mil. Inovio Pharmaceuticals's total shares outstanding is 25.91 Mil. Inovio Pharmaceuticals's float percentage of total shares outstanding is 99.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Inovio Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Inovio Pharmaceuticals's Institutional Ownership is 9.91%.

Inovio Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Inovio Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.73/25.91
=99.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
MGNX AGEN XERS EPIX RVNC INZY PSTX CRMD XOMA MRSN OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
INO:USA INO:Mexico
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Website
https://www.inovio.com
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines